Why cancer changes the way you think about health

James O’Mahoney says what came after his treatment inspired a new perspective on living well for as long as possible ...
Pharmaceutical Technology on MSN

FDA widens Vertex’s Casgevy use for paediatric patients

Children as young as two with either sickle cell disease or thalassemia are now eligible for the gene therapy.

Mitchell's Ann Temple breathing in a new life following double-lung transplant

Ann Temple walks up the steps of her Mitchell home just because she can. "I bet I do it 10 times a day, and it's just like walking on level ground," she said, glancing over at the ...

Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY ® (exagamglogene autotemcel) for the treatment ...